Akero Therapeutics Price Patterns
| AKRODelisted Stock | USD 54.65 0.00 0.00% |
Momentum 72
Buy Stretched
Oversold | Overbought |
Using Akero Therapeutics hype-based prediction, you can estimate the value of Akero Therapeutics from the perspective of Akero Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Akero Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Akero because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Akero Therapeutics after-hype prediction price | USD 54.64 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Akero |
Akero Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Akero Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Akero Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Akero Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Akero Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Akero Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Akero Therapeutics' historical news coverage. Akero Therapeutics' after-hype downside and upside margins for the prediction period are 54.49 and 54.79, respectively. We have considered Akero Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Akero Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Akero Therapeutics is based on 3 months time horizon.
Akero Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Akero Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Akero Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Akero Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 0.15 | 0.01 | 0.05 | 4 Events / Month | 9 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
54.65 | 54.64 | 0.02 |
|
Akero Therapeutics Hype Timeline
Akero Therapeutics is presently traded for 54.65. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.05. Akero is projected to decline in value after the next headline, with the price expected to drop to 54.64. The average volatility of media hype impact on the company price is about 60.0%. The price decrease on the next news is expected to be -0.02%, whereas the daily expected return is presently at 0.04%. The volatility of related hype on Akero Therapeutics is about 11.98%, with the expected price after the next announcement by competition of 54.60. About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Akero Therapeutics was presently reported as 11.95. The company has Price/Earnings To Growth (PEG) ratio of 0.93. Akero Therapeutics recorded a loss per share of 3.75. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 4 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.Akero Therapeutics Related Hype Analysis
Having access to credible news sources related to Akero Therapeutics' direct competition is more important than ever and may enhance your ability to predict Akero Therapeutics' future price movements. Getting to know how Akero Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Akero Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KYMR | Kymera Therapeutics | 2.80 | 10 per month | 2.67 | 0.06 | 4.40 | (4.46) | 49.42 | |
| VKTX | Viking Therapeutics | 0.64 | 9 per month | 0.00 | (0.08) | 7.49 | (5.49) | 19.06 | |
| IMVT | Immunovant | 0.07 | 9 per month | 2.21 | 0.09 | 4.47 | (3.63) | 20.44 | |
| CRNX | Crinetics Pharmaceuticals | (6.82) | 10 per month | 2.45 | 0.06 | 3.94 | (4.63) | 19.30 | |
| NAMS | NewAmsterdam Pharma | (2.24) | 10 per month | 0.00 | (0.07) | 4.72 | (4.89) | 15.37 | |
| PRAX | Praxis Precision Medicines | (7.26) | 8 per month | 3.90 | 0.15 | 9.33 | (6.06) | 36.21 | |
| ACLX | Arcellx | (1.05) | 9 per month | 0.00 | (0.10) | 4.75 | (4.57) | 22.18 | |
| SLNO | Soleno Therapeutics | 0.95 | 9 per month | 0.00 | (0.17) | 5.16 | (4.91) | 28.47 | |
| CNTA | Centessa Pharmaceuticals PLC | (0.05) | 9 per month | 2.67 | 0.01 | 4.97 | (4.08) | 26.54 | |
| ACAD | ACADIA Pharmaceuticals | 0.44 | 10 per month | 1.51 | 0.06 | 3.31 | (2.46) | 9.79 |
Akero Therapeutics Additional Predictive Modules
Most predictive techniques to examine Akero price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Akero using various technical indicators. When you analyze Akero charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Akero Therapeutics Predictive Indicators
The successful prediction of Akero Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Akero Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Akero Therapeutics based on analysis of Akero Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Akero Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Akero Therapeutics's related companies.
Pair Trading with Akero Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akero Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Akero Stock
| 0.61 | PPERY | Bank Mandiri Persero Earnings Call This Week | PairCorr |
| 0.71 | TLKMF | Telkom Indonesia Tbk | PairCorr |
Moving against Akero Stock
| 0.72 | PBCRY | Bank Central Asia | PairCorr |
| 0.69 | MSFT | Microsoft | PairCorr |
| 0.63 | HPQ | HP Inc | PairCorr |
| 0.54 | BKRKY | Bank Rakyat | PairCorr |
| 0.44 | PG | Procter Gamble | PairCorr |
| 0.37 | BKRKF | PT Bank Rakyat | PairCorr |
The ability to find closely correlated positions to Akero Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akero Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akero Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akero Therapeutics to buy it.
The correlation of Akero Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akero Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Akero Stock
If you are still planning to invest in Akero Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akero Therapeutics' history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |